Ampio Pharmaceuticals, Inc. (AMPE)
OTCMKTS
· Delayed Price · Currency is USD
0.0218
+0.0001 (0.46%)
Apr 25, 2025, 10:17 AM EDT
Ampio Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
24.69K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |
Ampio Pharmaceuticals News
- 1 year ago - Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation - PRNewsWire
- 1 year ago - Ampio Announces Voluntary Delisting and SEC Deregistration - PRNewsWire
- 1 year ago - Ampio Provides Update on Results from Pre-IND Enabling Studies - PRNewsWire
- 1 year ago - Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions - PRNewsWire
- 1 year ago - Ampio Pharmaceuticals to Present at the Emerging Growth Conference - PRNewsWire
- 1 year ago - Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201 - PRNewsWire
- 1 year ago - Ampio Pharmaceuticals Announces Reverse Stock Split - PRNewsWire
- 2 years ago - Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock - PRNewsWire